Literature DB >> 27190866

Idiopathic Pulmonary Fibrosis and Myasthenia Gravis: An Unusual Association.

Bharti Chogtu1, Daliparty Vasudev Malik2, Rahul Magazine3.   

Abstract

Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrosing lung condition with high morbidity and mortality, accounting for about 25% of the cases of interstitial lung diseases. It usually has a progressive course resulting in death due to respiratory failure. Myasthenia Gravis (MG) is an autoimmune neuromuscular disease, caused by antibody mediated activity against acetylcholine receptor at the neuromuscular junction. It is characterized by fluctuating muscle weakness and fatigue. Extensive literature search did not reveal any case report of an association between these two conditions. Here we present a case of a patient with IPF who also developed MG. The diagnosis of IPF was based on High Resolution Computed Tomography (HRCT) of the lung and that of MG was based on clinical criteria and electrophysiological testing. The case was successfully managed.

Entities:  

Keywords:  Interstitial pneumonia; N-acetyl cysteine; Repetitive nerve stimulation

Year:  2016        PMID: 27190866      PMCID: PMC4866164          DOI: 10.7860/JCDR/2016/17354.7596

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  5 in total

Review 1.  Acetylcholinesterase inhibitor treatment for myasthenia gravis.

Authors:  Man Mohan Mehndiratta; Sanjay Pandey; Thierry Kuntzer
Journal:  Cochrane Database Syst Rev       Date:  2014-10-13

Review 2.  Idiopathic pulmonary fibrosis: evolving concepts.

Authors:  Jay H Ryu; Teng Moua; Craig E Daniels; Thomas E Hartman; Eunhee S Yi; James P Utz; Andrew H Limper
Journal:  Mayo Clin Proc       Date:  2014-05-24       Impact factor: 7.616

3.  The difficulty in confirming clinical diagnosis of myasthenia gravis in a seronegative patient: a possible neurophysiological approach.

Authors:  P Caliandro; A Evoli; E Stålberg; G Granata; P Tonali; L Padua
Journal:  Neuromuscul Disord       Date:  2009-10-28       Impact factor: 4.296

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  Eric B Meltzer; Paul W Noble
Journal:  Orphanet J Rare Dis       Date:  2008-03-26       Impact factor: 4.123

5.  Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.

Authors:  Luca Richeldi; Adalberto Sperb Rubin; Sergey Avdeev; Zarir F Udwadia; Zuo Jun Xu
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.